Sumarios de Revistas

Lo último en... European Urology Supplements:

Estimating the Impact of COVID-19 on Urology: Data from a Large Nationwide Cohort The impact of the coronavirus disease 2019 (COVID-19) pandemic on urology worldwide has been the subject of frequent speculation, but population-level estimates on changes in urology care are sparsely reported. Here, we use newly released data from a large USA-based cohort to provide further insight into the impact of the pandemic on our field. For a final cohort of 900,900 patient encounters in 418 hospitals, we describe an approximately 20% decrease in urology-specific emergency room (ER) visits (19.4%, 95% confidence interval [CI] 17.4–21.5%), admissions to a urology service (19.3%, 95% CI 13.7–24.9%), and ambulatory urology surgeries (22.9%, 95% CI 13.2–32.6%) during March 2020 relative to baseline. Major Urological Cancer Surgery for Patients is Safe and Surgical Training Should Be Encouraged During the COVID-19 Pandemic: A Multicentre Analysis of 30-day Outcomes COVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with high risk of progression. We report outcomes for major GU cancer operations, namely radical prostatectomy (RP), radical cystectomy (RC), radical nephrectomy (RN), partial nephrectomy (PN), and nephroureterectomy performed at 13 major GU cancer centres across the UK between March 1 and May 5, 2020. A total of 598 such operations were performed. Four patients (0.7%) developed COVID-19 postoperatively. Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers The study results recommend considering strategies for early detection and prevention of second primary cancer. Readily available information on lifestyle (eg, smoking) and family history (eg, prostate cancer) may reveal targets for risk reduction with prognostic benefits. Active Surveillance—Is It Feasible for Intermediate-risk Localised Prostate Cancer? Active surveillance is an appropriate option for carefully selected patients with intermediate-risk localised prostate cancer, provided that the patient is well informed about the risks and benefits and close structured monitoring is maintained. Practice Patterns Among Penile Cancer Surgeons Performing Dynamic Sentinel Lymph Node Biopsy and Radical Inguinal Lymph Node Dissection in Men with Penile Cancer: A eUROGEN Survey Dynamic sentinel lymph node biopsy (DSNB) and radical inguinal lymph node dissection (ILND) are important in the management of penile cancer patients, but high-level evidence for preoperative, perioperative, and postoperative management remains scarce. According to an online survey of 35 surgeons from ten European countries, 57% perform >10 ILND procedures per year and 86% offer DSNB. Furthermore, management differs substantially for dye injection site, use of lymphoscintigraphy, preferred incision sites, techniques for lymphatic control, duration of empiric antibiotic therapy, perioperative thromboprophylaxis, time points for drain removal, and definition of the ILND dissection floor. The STHLM3-model, Risk-based Prostate Cancer Testing Identifies Men at High Risk Without Inducing Negative Psychosocial Effects Performing a risk-based prostate cancer test did not appear to induce negative psychosocial effects. Being assessed as having low or intermediate risk was associated with decreased worry levels 5 mo after prostate cancer testing compared with the levels at baseline 3 mo before the test. Minimally Invasive Buccal Mucosa Dorsal Graft for Female Distal Urethroplasty Female urethral stricture (FUS) represents a sporadic condition. There is a lack of data and standardized guidelines on diagnostics and therapeutics. Several surgical techniques have been described for FUS urethroplasty, among which the flap-based or graft-based ones are most reported. Buccal mucosa graft (BMG) represents the gold standard for male urethroplasty, and this can theoretically be applied also to FUS treatment. Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice The effect of docetaxel for metastatic hormone-sensitive prostate cancer patients treated in routine practice appears comparable with the overall efficacy reported in the literature. Selection of patients will influence the results in clinical practice and clinical studies. Re: Mikkel Fode, Christian Fuglesang S. Jensen, Peter B. Østergren. How Should the Medical Community Respond to the Low Quality of Medical Information on Social Media? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.050 We read with great interest the recent Platinum Priority editorial by Fode et al [1]. The authors express the opinion that the medical community should take measures to address the low quality of medical information on social media. We agree that the medical community should play their role in spreading correct, high-quality medical information. However, the authorities and the companies that run social media platforms should also respond to this issue with their own steps. Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms The use of the Stockholm3 blood test or prostate-specific antigen density might improve the detection of prostate cancer among men with lower urinary tract symptoms. Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study Most metastatic urothelial tract cancer patients receiving chemotherapy in the real-world clinical setting at Danish oncology departments receive cisplatin-based treatment. Survival in our patient cohort was comparable with the survival reported in clinical trials and in other real-world studies in this patient group. Copyright page Contents Editorial Board

Este mes en... European Urology

El mes que viene en... Journal of Urology